These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 33811324)

  • 1. Evaluation of Switch-to-Brand Rates as a Potential Signal for Therapeutic Equivalency of Generic Antidepressants: A Real-World Retrospective Cohort Study.
    Kalaria S; Spence O; Hong K; dosReis S; Gopalakrishnan M
    Clin Pharmacol Ther; 2021 Aug; 110(2):443-451. PubMed ID: 33811324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of generic switching on concerns about medicine and non-persistence among Danish adults in a general practice setting.
    Rathe JØ
    Dan Med J; 2015 Oct; 62(10):B5148. PubMed ID: 26441397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discontinuation rates and health care costs in adult patients starting generic versus brand SSRI or SNRI antidepressants in commercial health plans.
    Vlahiotis A; Devine ST; Eichholz J; Kautzner A
    J Manag Care Pharm; 2011 Mar; 17(2):123-32. PubMed ID: 21348545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Switch-backs associated with generic drugs approved using product-specific determinations of therapeutic equivalence.
    Gagne JJ; Polinski JM; Jiang W; Dutcher SK; Xie J; Lii J; Fulchino LA; Kesselheim AS
    Pharmacoepidemiol Drug Saf; 2016 Aug; 25(8):944-52. PubMed ID: 27102378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resource use and cost implications of switching among warfarin formulations in atrial fibrillation patients.
    Kwong WJ; Kamat S; Fang C
    Ann Pharmacother; 2012 Dec; 46(12):1609-16. PubMed ID: 23150608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effectiveness of generic and brand-name medication use: A database study of US health insurance claims.
    Desai RJ; Sarpatwari A; Dejene S; Khan NF; Lii J; Rogers JR; Dutcher SK; Raofi S; Bohn J; Connolly JG; Fischer MA; Kesselheim AS; Gagne JJ
    PLoS Med; 2019 Mar; 16(3):e1002763. PubMed ID: 30865626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brand-Name Antidepressants Outperform Their Generic Counterparts in Preventing Hospitalization for Depression: The Real-World Evidence from Taiwan.
    Hsu CW; Lee SY; Yang YH; Wang LJ
    Int J Neuropsychopharmacol; 2020 Dec; 23(10):653-661. PubMed ID: 32598470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Generic-to-Brand Switchback Rates Between Generic and Authorized Generic Drugs.
    Hansen RA; Qian J; Berg R; Linneman J; Seoane-Vazquez E; Dutcher SK; Raofi S; Page CD; Peissig P
    Pharmacotherapy; 2017 Apr; 37(4):429-437. PubMed ID: 28152215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generic escitalopram initiation and substitution among Medicare beneficiaries: A new user cohort study.
    Li C; Chen L; Huo N; Mishuk AU; Hansen RA; Harris I; Kiptanui Z; Wang Z; Qian J
    PLoS One; 2020; 15(4):e0232226. PubMed ID: 32353006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generic switching and non-persistence among medicine users: a combined population-based questionnaire and register study.
    Rathe J; Andersen M; Jarbøl DE; dePont Christensen R; Hallas J; Søndergaard J
    PLoS One; 2015; 10(3):e0119688. PubMed ID: 25775472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic equivalence of antipsychotics and antidepressants - A systematic review.
    Cessak G; Rokita K; Dąbrowska M; Sejbuk-Rozbicka K; Zaremba A; Mirowska-Guzel D; Bałkowiec-Iskra E
    Pharmacol Rep; 2016 Apr; 68(2):217-23. PubMed ID: 26922520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Choice of generic versus brand-name antidepressants in a regulated prescription drug market: evidence from Taiwan.
    Liu YM; Ou HT; Yang YK
    J Ment Health Policy Econ; 2014 Dec; 17(4):163-72. PubMed ID: 25599280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brand and generic use of inhalation medication and frequency of switching in children and adults: A population-based cohort study.
    Engelkes M; van Blijderveen JC; Overbeek JA; Kuiper J; Herings RCM; Sturkenboom MCJM; de Jongste JC; Verhamme KMC; Janssens HM
    J Asthma; 2018 Oct; 55(10):1086-1094. PubMed ID: 29185812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Evaluation of Health Service Impacts Consequent to Switching from Brand to Generic Venlafaxine in New Zealand under Conditions of Price Neutrality.
    Lessing C; Ashton T; Davis P
    Value Health; 2015 Jul; 18(5):646-54. PubMed ID: 26297093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Switching Patterns in FDA's Sentinel System: A New Tool to Assess Generic Drugs.
    Gagne JJ; Popovic JR; Nguyen M; Sandhu SK; Greene P; Izem R; Jiang W; Wang Z; Zhao Y; Petrone AB; Wagner AK; Dutcher SK
    Drug Saf; 2018 Dec; 41(12):1313-1323. PubMed ID: 30120741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational use of generic psychotropic drugs.
    Carbon M; Correll CU
    CNS Drugs; 2013 May; 27(5):353-65. PubMed ID: 23620145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in rates of switchbacks after switching from branded to authorized generic and branded to generic drug products: cohort study.
    Desai RJ; Sarpatwari A; Dejene S; Khan NF; Lii J; Rogers JR; Dutcher SK; Raofi S; Bohn J; Connolly J; Fischer MA; Kesselheim AS; Gagne JJ
    BMJ; 2018 Apr; 361():k1180. PubMed ID: 29615391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral generic tacrolimus initiation and substitution in the Medicaid population: a new user cohort study.
    Chen L; Li C; Huo N; Mishuk AU; Hansen RA; Harris I; Kiptanui Z; Qian J
    Curr Med Res Opin; 2020 Sep; 36(9):1533-1540. PubMed ID: 32644886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is associated with increased side effects and lower perceived efficacy following switching to a generic medicine? A New Zealand cross-sectional patient survey.
    MacKrill K; Petrie KJ
    BMJ Open; 2018 Oct; 8(10):e023667. PubMed ID: 30341138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generic and therapeutic statin switches and disruptions in therapy.
    Chapman RH; Benner JS; Girase P; Benigno M; Axelsen K; Liu LZ; Nichol MB
    Curr Med Res Opin; 2009 May; 25(5):1247-60. PubMed ID: 19344292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.